echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Pharmaceutical headliner AstraZeneta sells two cardiovascular drugs for $400 million

    Pharmaceutical headliner AstraZeneta sells two cardiovascular drugs for $400 million

    • Last Update: 2020-11-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    (2020/11/02) Modified CAR-T failure frequently; Japanese pharmaceutical representative system: Peizhang induction is only the appearance of the fundamental reform of the system is the focus; take you to the pharmaceutical and biological industry financial report - which are the most "lost" "gold"; asymptomatic infection surge! An inventory of the latest developments in the world's new crown vaccine... (Click on the title to get the original article) AstraZeneca's $400 million sale of two cardiovascular drugs on the morning of October 30, AstraZeneca said it would sell two cardiovascular drugs, Atalcand and Atalcan, for $400 million. The commercial rights to d Plus (Candizatan hydrochlorochlorophenidate tablets) were sold to German company Cheplapharm Arzneimittel GmbH, two drugs approved for the treatment of heart failure and hypertension, respectively, and are currently available in about 70 countries around the world.
    : AstraZeneta has made intensive strategic sales of mature drugs in recent years.
    the U.S. chinese medicine source modified CAR-T failure frequently these two days modified CAR-T enterprise Unum and Bellicum have issued adverse news.
    BLCM announced a 79% cut yesterday and will focus on developing bpX-601s targeting PSCA and BPX-603 targeting HER2.
    BPX-601 only produces some stable diseases in solid tumors without any response, while BPX-603 is just beginning to be clinical and faces a variety of new HER2 therapies.
    : CAR-T is undoubtedly one of the most cutting-edge medical technologies technology today.
    the "E drug manager" Japanese medicine representative system: PeiZhang induction is only the appearance of the fundamental reform of the system is the focus! Last week, the Japan Medical Representative (MR) Identification Center published the MR Identification Framework, which stipulates that from April next year, Japan's pharmaceutical representatives will be obliged to wear an MR badge in addition to a certificate of identification at work.
    the news that "Japanese medical representatives will be on duty" was swiped at home.
    headlines: Reform? Revolution? New Kangjie takes you to the pharmaceutical and biological industry financial results - which are the most "lost" "gold"? According to shenwan industry classification, A-share pharmaceutical bio-sector listed companies a total of 352.
    the first three quarters of 2020, the 352 pharmaceutical companies achieved a total operating income of 1330 billion yuan, of which 198.1 billion yuan was spent on sales expenses, accounting for 14.9% of operating income.
    : Pharmaceutical biology industry sales costs "high" has a long history.
    China's medical ecosystem is ushering in five great changes! China's medical ecosystem is not formed in a day, with decades of politics, economy and many other factors, with the advent of a new era, the introduction of a series of national policies, China's medical ecosystem is also ushering in many great changes.
    headlines: Government and markets walk on two legs.
    firestone creation, asymptomatic infection surges! The latest progress of the global new crown vaccine inventory as the public's vigilance against the new crown pneumonia gradually decreased, before the new 137 cases of asymptomatic infection in Kashgar, Xinjiang, no doubt gave everyone a "winter alarm."
    According to the latest notification from the Xinjiang Uygur Autonomous Region Health and Health Commission, as of 24 hours on October 31, there were 54 confirmed cases (6 cases of severe illness) in Xinjiang (including the Corps) and 219 cases of asymptomatic infection, all from Kashgar and Aktau counties in Kashgar.
    : Overseas outbreak situation is serious, vaccine is the best way to control the new crown outbreak.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.